Angela Yellson

Doctor of Medicine,  Toronto General - University Health Network 

Location: Germany

Consulting Services

Sales and Marketing Data Science-Bioinformatics Hospital-Pharmacy-Insurance

Areas Of Interest

Antifreeze Proteins, Type III Acceptance Process Bombyxs Hemimotor Epilepsies Spectrum Disorders, Autism Lepus Guibourtia Costimulatory Molecule, B7-1 Cytoplasm Crushing Skull Injuries Afferent Loop Syndrome Duck Hepatitis Viruses Abscess, Epidural Plant Nurseries N-Glycanase Colony-Forming Unit, Erythroid Nonne Milroy Lymphedema Automated Medical Record Systems Minke Whales Lentinulas Contraindication Osseointegration Vigilance, Cortical Signal-Transducing Receptor gp130 Therapeutics Committee Export Signals, Nuclear T-Cell Acute Lymphocytic Leukemia Protein 1 Aminohydrolase, Guanine Photograph, Moire PPARGC-1-alpha Protein

Professional Narrative

Dr. Angela Yellson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Yellson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Medical Writer, Harvard Med 2004
Assistant Professor, Harvard Med 2009

Education

Director Medicine, Harvard Medical School 2015
Doctor of medicine, Baylor College 1999

Referees


Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :